Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Kidney Diseases Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Enzyme Replacement Therapy
1.2.3 Monoclonal Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rare Kidney Diseases Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Atypical Hemolytic Uremic Syndrome
1.3.3 Nephropathic Cystinosis
1.3.4 Lupus Nephritis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Kidney Diseases Treatment Market Perspective (2018-2033)
2.2 Rare Kidney Diseases Treatment Growth Trends by Region
2.2.1 Global Rare Kidney Diseases Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Rare Kidney Diseases Treatment Historic Market Size by Region (2018-2023)
2.2.3 Rare Kidney Diseases Treatment Forecasted Market Size by Region (2024-2033)
2.3 Rare Kidney Diseases Treatment Market Dynamics
2.3.1 Rare Kidney Diseases Treatment Industry Trends
2.3.2 Rare Kidney Diseases Treatment Market Drivers
2.3.3 Rare Kidney Diseases Treatment Market Challenges
2.3.4 Rare Kidney Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Kidney Diseases Treatment Players by Revenue
3.1.1 Global Top Rare Kidney Diseases Treatment Players by Revenue (2018-2023)
3.1.2 Global Rare Kidney Diseases Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Rare Kidney Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare Kidney Diseases Treatment Revenue
3.4 Global Rare Kidney Diseases Treatment Market Concentration Ratio
3.4.1 Global Rare Kidney Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Kidney Diseases Treatment Revenue in 2022
3.5 Rare Kidney Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Rare Kidney Diseases Treatment Product Solution and Service
3.7 Date of Enter into Rare Kidney Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Kidney Diseases Treatment Breakdown Data by Type
4.1 Global Rare Kidney Diseases Treatment Historic Market Size by Type (2018-2023)
4.2 Global Rare Kidney Diseases Treatment Forecasted Market Size by Type (2024-2033)
5 Rare Kidney Diseases Treatment Breakdown Data by Application
5.1 Global Rare Kidney Diseases Treatment Historic Market Size by Application (2018-2023)
5.2 Global Rare Kidney Diseases Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Rare Kidney Diseases Treatment Market Size (2018-2033)
6.2 North America Rare Kidney Diseases Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Rare Kidney Diseases Treatment Market Size by Country (2018-2023)
6.4 North America Rare Kidney Diseases Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare Kidney Diseases Treatment Market Size (2018-2033)
7.2 Europe Rare Kidney Diseases Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Rare Kidney Diseases Treatment Market Size by Country (2018-2023)
7.4 Europe Rare Kidney Diseases Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Kidney Diseases Treatment Market Size (2018-2033)
8.2 Asia-Pacific Rare Kidney Diseases Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare Kidney Diseases Treatment Market Size (2018-2033)
9.2 Latin America Rare Kidney Diseases Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Rare Kidney Diseases Treatment Market Size by Country (2018-2023)
9.4 Latin America Rare Kidney Diseases Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Kidney Diseases Treatment Market Size (2018-2033)
10.2 Middle East & Africa Rare Kidney Diseases Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aurinia Pharmaceuticals
11.1.1 Aurinia Pharmaceuticals Company Detail
11.1.2 Aurinia Pharmaceuticals Business Overview
11.1.3 Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Introduction
11.1.4 Aurinia Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.1.5 Aurinia Pharmaceuticals Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Rare Kidney Diseases Treatment Introduction
11.2.4 Sanofi Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Calliditas Therapeutics AB
11.3.1 Calliditas Therapeutics AB Company Detail
11.3.2 Calliditas Therapeutics AB Business Overview
11.3.3 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Introduction
11.3.4 Calliditas Therapeutics AB Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.3.5 Calliditas Therapeutics AB Recent Development
11.4 Shire
11.4.1 Shire Company Detail
11.4.2 Shire Business Overview
11.4.3 Shire Rare Kidney Diseases Treatment Introduction
11.4.4 Shire Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.4.5 Shire Recent Development
11.5 GSK
11.5.1 GSK Company Detail
11.5.2 GSK Business Overview
11.5.3 GSK Rare Kidney Diseases Treatment Introduction
11.5.4 GSK Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.5.5 GSK Recent Development
11.6 Amicus Therapeutics
11.6.1 Amicus Therapeutics Company Detail
11.6.2 Amicus Therapeutics Business Overview
11.6.3 Amicus Therapeutics Rare Kidney Diseases Treatment Introduction
11.6.4 Amicus Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.6.5 Amicus Therapeutics Recent Development
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Company Detail
11.7.2 Horizon Therapeutics Business Overview
11.7.3 Horizon Therapeutics Rare Kidney Diseases Treatment Introduction
11.7.4 Horizon Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.7.5 Horizon Therapeutics Recent Development
11.8 Advicenne
11.8.1 Advicenne Company Detail
11.8.2 Advicenne Business Overview
11.8.3 Advicenne Rare Kidney Diseases Treatment Introduction
11.8.4 Advicenne Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.8.5 Advicenne Recent Development
11.9 Reata Pharmaceuticals
11.9.1 Reata Pharmaceuticals Company Detail
11.9.2 Reata Pharmaceuticals Business Overview
11.9.3 Reata Pharmaceuticals Rare Kidney Diseases Treatment Introduction
11.9.4 Reata Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.9.5 Reata Pharmaceuticals Recent Development
11.10 Alexion Pharmaceuticals
11.10.1 Alexion Pharmaceuticals Company Detail
11.10.2 Alexion Pharmaceuticals Business Overview
11.10.3 Alexion Pharmaceuticals Rare Kidney Diseases Treatment Introduction
11.10.4 Alexion Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.10.5 Alexion Pharmaceuticals Recent Development
11.11 Otsuka Pharmaceutical
11.11.1 Otsuka Pharmaceutical Company Detail
11.11.2 Otsuka Pharmaceutical Business Overview
11.11.3 Otsuka Pharmaceutical Rare Kidney Diseases Treatment Introduction
11.11.4 Otsuka Pharmaceutical Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.11.5 Otsuka Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Rare Kidney Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Others
Table 5. Global Rare Kidney Diseases Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Rare Kidney Diseases Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Rare Kidney Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Rare Kidney Diseases Treatment Market Share by Region (2018-2023)
Table 9. Global Rare Kidney Diseases Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Rare Kidney Diseases Treatment Market Share by Region (2024-2033)
Table 11. Rare Kidney Diseases Treatment Market Trends
Table 12. Rare Kidney Diseases Treatment Market Drivers
Table 13. Rare Kidney Diseases Treatment Market Challenges
Table 14. Rare Kidney Diseases Treatment Market Restraints
Table 15. Global Rare Kidney Diseases Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Rare Kidney Diseases Treatment Market Share by Players (2018-2023)
Table 17. Global Top Rare Kidney Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2022)
Table 18. Ranking of Global Top Rare Kidney Diseases Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Rare Kidney Diseases Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rare Kidney Diseases Treatment Product Solution and Service
Table 22. Date of Enter into Rare Kidney Diseases Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Rare Kidney Diseases Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Rare Kidney Diseases Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Rare Kidney Diseases Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Rare Kidney Diseases Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Rare Kidney Diseases Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Rare Kidney Diseases Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Rare Kidney Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Rare Kidney Diseases Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Aurinia Pharmaceuticals Company Detail
Table 48. Aurinia Pharmaceuticals Business Overview
Table 49. Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 50. Aurinia Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 51. Aurinia Pharmaceuticals Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Rare Kidney Diseases Treatment Product
Table 55. Sanofi Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Calliditas Therapeutics AB Company Detail
Table 58. Calliditas Therapeutics AB Business Overview
Table 59. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product
Table 60. Calliditas Therapeutics AB Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 61. Calliditas Therapeutics AB Recent Development
Table 62. Shire Company Detail
Table 63. Shire Business Overview
Table 64. Shire Rare Kidney Diseases Treatment Product
Table 65. Shire Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 66. Shire Recent Development
Table 67. GSK Company Detail
Table 68. GSK Business Overview
Table 69. GSK Rare Kidney Diseases Treatment Product
Table 70. GSK Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 71. GSK Recent Development
Table 72. Amicus Therapeutics Company Detail
Table 73. Amicus Therapeutics Business Overview
Table 74. Amicus Therapeutics Rare Kidney Diseases Treatment Product
Table 75. Amicus Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 76. Amicus Therapeutics Recent Development
Table 77. Horizon Therapeutics Company Detail
Table 78. Horizon Therapeutics Business Overview
Table 79. Horizon Therapeutics Rare Kidney Diseases Treatment Product
Table 80. Horizon Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 81. Horizon Therapeutics Recent Development
Table 82. Advicenne Company Detail
Table 83. Advicenne Business Overview
Table 84. Advicenne Rare Kidney Diseases Treatment Product
Table 85. Advicenne Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 86. Advicenne Recent Development
Table 87. Reata Pharmaceuticals Company Detail
Table 88. Reata Pharmaceuticals Business Overview
Table 89. Reata Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 90. Reata Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 91. Reata Pharmaceuticals Recent Development
Table 92. Alexion Pharmaceuticals Company Detail
Table 93. Alexion Pharmaceuticals Business Overview
Table 94. Alexion Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 95. Alexion Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 96. Alexion Pharmaceuticals Recent Development
Table 97. Otsuka Pharmaceutical Company Detail
Table 98. Otsuka Pharmaceutical Business Overview
Table 99. Otsuka Pharmaceutical Rare Kidney Diseases Treatment Product
Table 100. Otsuka Pharmaceutical Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 101. Otsuka Pharmaceutical Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Kidney Diseases Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Rare Kidney Diseases Treatment Market Share by Type: 2022 VS 2033
Figure 3. Enzyme Replacement Therapy Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Others Features
Figure 6. Global Rare Kidney Diseases Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Rare Kidney Diseases Treatment Market Share by Application: 2022 VS 2033
Figure 8. Atypical Hemolytic Uremic Syndrome Case Studies
Figure 9. Nephropathic Cystinosis Case Studies
Figure 10. Lupus Nephritis Case Studies
Figure 11. Others Case Studies
Figure 12. Rare Kidney Diseases Treatment Report Years Considered
Figure 13. Global Rare Kidney Diseases Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Rare Kidney Diseases Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Rare Kidney Diseases Treatment Market Share by Region: 2022 VS 2033
Figure 16. Global Rare Kidney Diseases Treatment Market Share by Players in 2022
Figure 17. Global Top Rare Kidney Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Rare Kidney Diseases Treatment Revenue in 2022
Figure 19. North America Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Rare Kidney Diseases Treatment Market Share by Country (2018-2033)
Figure 21. United States Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Rare Kidney Diseases Treatment Market Share by Country (2018-2033)
Figure 25. Germany Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Rare Kidney Diseases Treatment Market Share by Region (2018-2033)
Figure 33. China Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Rare Kidney Diseases Treatment Market Share by Country (2018-2033)
Figure 41. Mexico Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Rare Kidney Diseases Treatment Market Share by Country (2018-2033)
Figure 45. Turkey Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Aurinia Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 48. Sanofi Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 49. Calliditas Therapeutics AB Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 50. Shire Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 51. GSK Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 52. Amicus Therapeutics Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 53. Horizon Therapeutics Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 54. Advicenne Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 55. Reata Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 56. Alexion Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 57. Otsuka Pharmaceutical Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed